Knott David M Jr
Reports for
Dorset Partners LLC
Filing Date
Global Rank
#4,890
/ 8,700
▲ 1886
Top Industry
Biotechnology
45.2%
Period ended 2 months ago
Filed Aug 12, 2026 · 32d
19 quarters · since Dec 2021
Portfolio Concentration
74 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
18.6%
+1.7 pts
Top 5
49.1%
+1.2 pts
Top 10
68.4%
+3.6 pts
HHI
770
Diversified+45
Portfolio Trend
19 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 57.2% | $99,426,758 |
| Financial Services | 20.9% | $36,257,855 |
| Communication Services | 18.6% | $32,301,428 |
| Technology | 1.4% | $2,462,065 |
| Unclassified | 0.6% | $1,046,045 |
| Energy | 0.4% | $686,379 |
| Consumer Defensive | 0.3% | $436,968 |
| Industrials | 0.2% | $427,199 |
| Real Estate | 0.2% | $315,072 |
| Consumer Cyclical | 0.1% | $203,382 |
| Basic Materials | 0.1% | $135,132 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
16 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CNTB | Connect Biopharma Holdings Ltd | +57,027 | 444,862 | $1,058,771 | |
| ARDX | Ardelyx, Inc. | +56,168 | 263,168 | $1,342,156 | |
| VSTM | Verastem, Inc. | +51,000 | 155,000 | $592,100 | |
| CGEM | Cullinan Therapeutics, Inc. | +44,982 | 69,182 | $1,259,804 | |
| HELP | Cybin Inc. | +20,000 | 370,000 | $2,445,700 | |
| SNDX | Syndax Pharmaceuticals Inc | +15,245 | 437,245 | $9,558,175 | |
| RLMD | Relmada Therapeutics, Inc. | +11,700 | 451,000 | $3,120,920 | |
| SLDB | Solid Biosciences Inc. | +9,065 | 56,208 | $561,517 | |
| COGT | Cogent Biosciences, Inc. | +7,081 | 111,081 | $4,298,834 | |
| TVTX | Travere Therapeutics, Inc. | +6,649 | 147,282 | $8,367,090 | |
| RARE | Ultragenyx Pharmaceutical Inc. | +5,000 | 38,069 | $1,271,123 | |
| BBIO | BridgeBio Pharma, Inc. | +2,850 | 92,850 | $6,915,468 | |
| AGIO | Agios Pharmaceuticals, Inc. | +2,000 | 95,058 | $3,527,602 | |
| ALKS | Alkermes plc. | +1,759 | 121,759 | $6,380,171 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | +1,000 | 3,000 | $1,610,850 | |
| PTHS | Pelthos Therapeutics Inc. | +1,000 | 22,073 | $623,782 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
5 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| TGTX | Tg Therapeutics, Inc. | −23,162 | 66,839 | $3,672,134 | |
| BMY | Bristol Myers Squibb Co | −11,622 | 2,000 | $115,240 | |
| JPM | Jpmorgan Chase & Co | −1,379 | 18,098 | $5,924,018 | |
| GOOGL | Alphabet Inc. | −300 | 91,420 | $32,301,428 | |
| OXY | Occidental Petroleum Corp /De/ | −194 | 469 | $22,779 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
8 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CLST | Catalyst Bancorp, Inc. | 114,000 | $1,882,140 | |
| SPRB | Spruce Biosciences, Inc. | 20,000 | $1,080,000 | |
| INSM | INSMED Inc | 4,253 | $453,454 | |
| LBRX | Lb Pharmaceuticals Inc | 12,965 | $420,779 | |
| CDNA | CareDx, Inc. | 13,630 | $388,455 | |
| QTTB | Q32 Bio Inc. | 30,412 | $387,448 | |
| ELVN | Enliven Therapeutics, Inc. | 6,183 | $313,787 | |
| BSX | Boston Scientific Corp | 6,000 | $256,080 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
16 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| JA | Janus Henderson AA-A CLO ETF | 93,528 | $4,711,005 | |
| BWX | State Street SPDR Bloomberg International Treasury Bond ETF | 15,000 | $1,915,950 | |
| CYTK | Cytokinetics Inc | 23,644 | $1,558,376 | |
| ADPV | Adaptiv Select ETF | 47,807 | $1,226,249 | |
| ADMA | Adma Biologics, Inc. | 60,200 | $542,402 | |
| EOLS | Evolus, Inc. | 99,338 | $408,279 | |
| LENZ | LENZ Therapeutics, Inc. | 33,732 | $308,647 | |
| DD | DuPont de Nemours, Inc. | 3,767 | $172,528 | |
| JSPR | Jasper Therapeutics, Inc. | 160,789 | $140,851 | |
| MREO | Mereo BioPharma Group plc | 300,337 | $99,111 | |
| — | 695 | $89,043 | ||
| BX | Blackstone Inc. | 210 | $24,147 | |
| UNH | Unitedhealth Group Inc | 57 | $15,423 | |
| — | 19,433 | $0 | ||
| — | 120,000 | $0 | ||
| CNTA | Centessa Pharmaceuticals plc | 39,000 | $0 | |
| No positions match the current search. | ||||
74 tracked positions ·
$173,698,283 total
· filing declares
86 positions · $189,178,234
· as of Jun 30, 2026
All sectors
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Showing 1–50
of 74 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| GOOGL |
Alphabet Inc.
Communication Services
|
Reduced | 91,420 | $32,301,428 | 18.60% | |
| APO |
Apollo Global Management, Inc.
Financial Services
|
Held | 225,000 | $26,619,750 | 15.33% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Added | 437,245 | $9,558,175 | 5.50% | |
| XERS |
Xeris Biopharma Holdings, Inc.
Healthcare
|
Held | 1,060,000 | $8,395,200 | 4.83% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
Added | 147,282 | $8,367,090 | 4.82% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Held | 63,000 | $7,722,540 | 4.45% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Added | 92,850 | $6,915,468 | 3.98% | |
| IOVA |
Iovance Biotherapeutics, Inc.
Healthcare
|
Held | 1,600,000 | $6,656,000 | 3.83% | |
| ALKS |
Alkermes plc.
Healthcare
|
Added | 121,759 | $6,380,171 | 3.67% | |
| JPM |
Jpmorgan Chase & Co
Financial Services
|
Reduced | 18,098 | $5,924,018 | 3.41% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Added | 111,081 | $4,298,834 | 2.47% | |
| TGTX |
Tg Therapeutics, Inc.
Healthcare
|
Reduced | 66,839 | $3,672,134 | 2.11% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
Added | 95,058 | $3,527,602 | 2.03% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Held | 181,000 | $3,324,970 | 1.91% | |
| RLMD |
Relmada Therapeutics, Inc.
Healthcare
|
Added | 451,000 | $3,120,920 | 1.80% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
Held | 81,241 | $2,504,660 | 1.44% | |
| HELP |
Cybin Inc.
Healthcare
|
Added | 370,000 | $2,445,700 | 1.41% | |
| RZLT |
Rezolute, Inc.
Healthcare
|
Held | 370,000 | $1,924,000 | 1.11% | |
| CLST |
Catalyst Bancorp, Inc.
Financial Services
|
NEW | 114,000 | $1,882,140 | 1.08% | |
| AB |
Alliancebernstein Holding L.P.
Financial Services
|
Held | 48,000 | $1,690,560 | 0.97% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
Added | 3,000 | $1,610,850 | 0.93% | |
| ATRC |
AtriCure, Inc.
Healthcare
|
Held | 51,400 | $1,438,172 | 0.83% | |
| DCGO |
DocGo Inc.
Healthcare
|
Held | 2,670,850 | $1,378,158 | 0.79% | |
| ARDX |
Ardelyx, Inc.
Healthcare
|
Added | 263,168 | $1,342,156 | 0.77% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Added | 38,069 | $1,271,123 | 0.73% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
Added | 69,182 | $1,259,804 | 0.73% | |
| JNJ |
Johnson & Johnson
Healthcare
|
Held | 4,922 | $1,250,040 | 0.72% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Held | 26,000 | $1,115,660 | 0.64% | |
| OBIO |
Orchestra BioMed Holdings, Inc.
Healthcare
|
Held | 253,651 | $1,094,504 | 0.63% | |
| SPRB |
Spruce Biosciences, Inc.
Healthcare
|
NEW | 20,000 | $1,080,000 | 0.62% | |
| CNTB |
Connect Biopharma Holdings Ltd
Healthcare
|
Added | 444,862 | $1,058,771 | 0.61% | |
|
|
Held | 5,500 | $1,046,045 | 0.60% | ||
| BIIB |
Biogen Inc.
Healthcare
|
Held | 4,000 | $864,240 | 0.50% | |
| PFE |
Pfizer Inc
Healthcare
|
Held | 32,337 | $778,674 | 0.45% | |
| AAPL |
Apple Inc.
Technology
|
Held | 2,494 | $721,663 | 0.42% | |
| CNQ |
CANADIAN NATURAL RESOURCES Ltd
Energy
|
Held | 16,800 | $663,600 | 0.38% | |
| PTHS |
Pelthos Therapeutics Inc.
Healthcare
|
Added | 22,073 | $623,782 | 0.36% | |
| IBM |
International Business Machines Corp
Technology
|
Held | 2,142 | $602,351 | 0.35% | |
| MSFT |
Microsoft Corp
Technology
|
Held | 1,600 | $596,832 | 0.34% | |
| VSTM |
Verastem, Inc.
Healthcare
|
Added | 155,000 | $592,100 | 0.34% | |
| KURA |
Kura Oncology, Inc.
Healthcare
|
Held | 52,767 | $578,853 | 0.33% | |
| SLDB |
Solid Biosciences Inc.
Healthcare
|
Added | 56,208 | $561,517 | 0.32% | |
| INSM |
INSMED Inc
Healthcare
|
NEW | 4,253 | $453,454 | 0.26% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
NEW | 12,965 | $420,779 | 0.24% | |
| CDNA |
CareDx, Inc.
Healthcare
|
NEW | 13,630 | $388,455 | 0.22% | |
| QTTB |
Q32 Bio Inc.
Healthcare
|
NEW | 30,412 | $387,448 | 0.22% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
NEW | 6,183 | $313,787 | 0.18% | |
| RHP |
Ryman Hospitality Properties, Inc.
Real Estate
|
Held | 2,400 | $308,520 | 0.18% | |
| AVGO |
Broadcom Inc.
Technology
|
Held | 710 | $268,202 | 0.15% | |
| KMB |
Kimberly Clark Corp
Consumer Defensive
|
Held | 2,400 | $263,448 | 0.15% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.